Clopidogrel in acute coronary syndromes: Where are we now?

被引：4
|
作者：
Bainey, Kevin R.
Lai, Tony F.
Mehta, Shamir R.
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
THROMBOSIS AND HAEMOSTASIS | 2011年 / 105卷 / 05期
关键词：
PROTON-PUMP INHIBITORS; ELEVATION MYOCARDIAL-INFARCTION; PLATELET REACTIVITY; ANTIPLATELET THERAPY; DOUBLE-BLIND; OUTCOMES; INTERVENTION; ASPIRIN; RISK; PRASUGREL;
D O I：
10.1160/TH10-10-0633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：766 / 773
页数：8
相关论文
共 50 条
  • [1] Suboptimal response to clopidogrel and the effect of prasugrel in acute coronary syndromes
    Johnston, L. R.
    Larsen, P. D.
    La Flamme, A. C.
    Michel, J. M.
    Simmonds, M. B.
    Harding, S. A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 995 - 999
  • [2] Clopidogrel "Resistance": Where are We Now?
    Qureshi, Zeshan
    Hobson, Alex R.
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 3 - 11
  • [3] Clopidogrel in acute coronary syndromes
    Chua, Doson
    Ignaszewski, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 998 - 1002
  • [4] Defining the optimal dose of aspirin and clopidogrel in acute coronary syndromes
    Gurm, Hitinder S.
    Eagle, Kim A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) : 148 - 150
  • [5] Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
    Mehta, Shamir R.
    Bassand, Jean-Pierre
    Chrolavicius, Susan
    Diaz, Rafael
    Eikelboom, John W.
    Fox, Keith A. A.
    Granger, Christopher B.
    Jolly, Sanjit
    Joyner, Campbell D.
    Rupprecht, Hans-Jurgen
    Widimsky, Petr
    Afzal, Rizwan
    Pogue, Janice
    Yusuf, Salim
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) : 930 - 942
  • [6] Antiplatelet therapy in acute coronary syndromes
    Grove, Erik L.
    Wurtz, Morten
    Thomas, Mark R.
    Kristensen, Steen Dalby
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (14) : 2133 - 2147
  • [7] Acute coronary syndrome in Australia: Where are we now and where are we going?
    Nadel, James
    Hewitt, Timothy
    Horton, Damien
    AUSTRALASIAN MEDICAL JOURNAL, 2015, 8 (11): : 149 - 156
  • [8] Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis, Dimitris
    Briasoulis, Alexandros
    Dhamrait, Sukhbir S.
    Antoniades, Charalambos
    Stefanadis, Christodoulos
    HEART, 2009, 95 (10) : 850 - 858
  • [9] Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
    Klingenberg, Roland
    Heg, Dik
    Raeber, Lorenz
    Carballo, David
    Nanchen, David
    Gencer, Baris
    Auer, Reto
    Jaguszewski, Milosz
    Staehli, Barbara E.
    Jakob, Philipp
    Templin, Christian
    Stefanini, Giulio G.
    Meier, Bernhard
    Vogt, Pierre
    Roffi, Marco
    Maier, Willibald
    Landmesser, Ulf
    Rodondi, Nicolas
    Mach, Francois
    Windecker, Stephan
    Jueni, Peter
    Luescher, Thomas F.
    Matter, Christian M.
    HEART, 2015, 101 (11) : 854 - 863
  • [10] Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Yudi, M. B.
    Clark, D. J.
    Farouque, O.
    Eccleston, D.
    Andrianopoulos, N.
    Duffy, S. J.
    Brennan, A.
    Lefkovits, J.
    Ramchand, J.
    Yip, T.
    Oqueli, E.
    Reid, C. M.
    Ajani, A. E.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (05) : 559 - 565
12345